SUZY AMOR: Open Payments
NPI 1568601490 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,138 in 46 payments from 9 companies in 2025. Trend: 2023 $375 · 2024 $1,025 · 2025 $1,138
Food & beverage: $1,138
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $452 |
| Organon LLC | 6 | $180 |
| UCB, Inc. | 12 | $158 |
| Incyte Corporation | 4 | $100 |
| PFIZER INC. | 2 | $78 |
| Amgen Inc. | 2 | $57 |
| Botanix SB Inc | 2 | $48 |
| Janssen Biotech, Inc. | 1 | $38 |
| Galderma Laboratories, L.P. | 1 | $26 |
Products named: RINVOQ, BOTOX, Bimzelx, OPZELURA, CIBINQO, SKYRIZI, VTAMA, OTEZLA.
Industry payments across MA — which companies pay providers there.
